These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5425292)

  • 1. Studies on beta-D-xylofuranosyl-6-thioguanine in mice.
    Kaneko T; LePage GA
    Cancer Res; 1970 Mar; 30(3):699-701. PubMed ID: 5425292
    [No Abstract]   [Full Text] [Related]  

  • 2. [Utilization of pyrimidine precursors in the tumor and liver of mice with Ehrlich ascites carcinoma].
    Fedorov NA; Matveenko VN; Tikhonova EF
    Biull Eksp Biol Med; 1970 Dec; 70(12):66-9. PubMed ID: 5503816
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic fate of 9-beta-d-xylofuranosyladenine in mice bearing susceptible tumor cells.
    Ellis DB; LePage GA
    Cancer Res; 1966 May; 26(5):893-7. PubMed ID: 5934802
    [No Abstract]   [Full Text] [Related]  

  • 4. Lack of activity of beta-2'-deoxythioguanosine against two tumors resistant to 6-thioguanine.
    Nelson JA; Kuhns JN; Carpenter JW
    Cancer Res; 1975 May; 35(5):1372-4. PubMed ID: 1168098
    [No Abstract]   [Full Text] [Related]  

  • 5. Biosynthesis de novo of purines and pyrimidines in Mesocestoides (Cestoda). I.
    Heath RL
    J Parasitol; 1970 Feb; 56(1):98-102. PubMed ID: 5413855
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic activity of the Ehrlich ascites cells in synthetic media and the significance of ascites serum addition.
    Miko M; Drobnica L
    Neoplasma; 1972; 19(3):163-73. PubMed ID: 5047461
    [No Abstract]   [Full Text] [Related]  

  • 7. METABOLIC EFFECTS OF 9-BUTYL-6-THIOGUANINE IN VIVO.
    KIMBALL AP; LEPAGE GA
    Cancer Res; 1963 Dec; 23():1792-9. PubMed ID: 14082874
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism of an antineoplastic methylhydrazine derivative in a P815 mouse neoplasm.
    Kreis W
    Cancer Res; 1970 Jan; 30(1):82-9. PubMed ID: 5441083
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective inhibition by sorbylhydroxamic acid of deoxyribonucleic acid synthesis in Ehrlich ascites tumor cells.
    Gale GR; Smith AB; Walker EM
    Cancer Res; 1970 Jan; 30(1):24-9. PubMed ID: 5441077
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibitors of nucleoside and nucleotide metabolism.
    Henderson JF; Paterson AR; Caldwell IC; Paul B; Chan MC; Lau KF
    Cancer Chemother Rep 2; 1972 Nov; 3(1):71-85. PubMed ID: 4676703
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of some cancerostatics on the cytology and on the nucleic acid content in Ehrlich ascites cells in vivo.
    Veselá H; Jelínek V; Kejhová I
    Neoplasma; 1965; 12(4):365-72. PubMed ID: 5854407
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluorinated pyrimidine aldehydes. Inhibition of nucleic acid and protein biosynthesis in Ehrlich ascites carcinoma cells in vitro.
    Chae CB; Irvin JL; Piantadosi C
    J Med Chem; 1968 May; 11(3):506-13. PubMed ID: 5656488
    [No Abstract]   [Full Text] [Related]  

  • 13. METABOLIC EFFECTS OF AN ANTIBIOTIC, NSC-51954, ON SUSCEPTIBLE AND RESISTANT TUMOR CELLS.
    SATO K; LEPAGE GA
    Cancer Res; 1965 May; 25():477-83. PubMed ID: 14297485
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunosuppressive and antitumor activity of periodate oxidation product of beta-D-ribosyl-6-methylthiopurine.
    Bell JP; Faures ML; LePage GA; Kimball AP
    Cancer Res; 1968 Apr; 28(4):782-7. PubMed ID: 4296939
    [No Abstract]   [Full Text] [Related]  

  • 15. Scheduling of arabinosylcytosine and 6-thioguanine therapy.
    LePage GA; White SC
    Cancer Res; 1973 May; 33(5):946-9. PubMed ID: 4703126
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mechanism of the antitumor action of 5-fluorouracil].
    Reztsova VV; Filov VA; Stukov AN
    Dokl Akad Nauk SSSR; 1980; 253(2):488-91. PubMed ID: 7428592
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the biochemical mode of action of a cytotoxic methylhydrazine derivative, N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide.
    Sartorelli AC; Tsunamura S
    Mol Pharmacol; 1966 Jul; 2(4):275-83. PubMed ID: 5968069
    [No Abstract]   [Full Text] [Related]  

  • 18. EFFECTS OF ANTIMITOTIC AGENTS ON EHRLICH ASCITES CELLS.
    PECORA PF; BALIS ME
    Biochem Pharmacol; 1964 Jul; 13():1071-81. PubMed ID: 14201129
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interference of immunological factors in the antitumoral activity of sarcolysine].
    Bonmassar E; Castagnone D; Celi ML; Melan F
    Arch Ital Patol Clin Tumori; 1968; 11(1):215-28. PubMed ID: 5745129
    [No Abstract]   [Full Text] [Related]  

  • 20. Biosynthesis de novo of purines and pyrimidines in Mesocestoides (Cestoda). II.
    Heath RL; Hart JL
    J Parasitol; 1970 Apr; 56(2):340-5. PubMed ID: 5445829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.